Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway | Zendy

Hanzi Xu | Zendy; Zhen Gong | Zendy; Siying Zhou | Zendy; SuJin Yang | Zendy; Dandan Wang | Zendy; Xiu Chen | Zendy; Jiaqi Wu | Zendy; Liucheng Liu | Zendy; Shanliang Zhong | Zendy; Jianhua Zhao | Zendy; Jinhai Tang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway

Author(s) -

Hanzi Xu,

Zhen Gong,

Siying Zhou,

SuJin Yang,

Dandan Wang,

Xiu Chen,

Jiaqi Wu,

Liucheng Liu,

Shanliang Zhong,

Jianhua Zhao,

Jinhai Tang

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000491886

Subject(s) - curcumin , apoptosis , motility , cell growth , flow cytometry , chemistry , pharmacology , cancer research , zebrafish , cell culture , nf κb , cell , biology , microbiology and biotechnology , biochemistry , genetics , gene

Emerging evidence suggests that curcumin possesses chemopreventive properties against various cancers. However, its poor bioavailability limits its clinical application. In this study, we aimed to utilize encapsulation in liposomes (Lipo) as a strategy for the clinical administration of curcumin for endometrial carcinoma (EC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research